NANOVERY

Nanovery is a biotechnology company developing a patented Nucleic Acid Nanorobotics (NANs) platform for enzyme-free detection and quantification of nucleic acid targets.

Synthetic DNA nanorobots generate fluorescent signals in response to specific sequences, enabling direct quantification of antisense oligonucleotides, siRNA, and microRNAs from complex biological samples using standard laboratory equipment.

Applications span RNA therapeutic bioanalysis for pharmaceutical research and a diagnostics pipeline targeting cancer and liver disease biomarkers.